Atlas Trials

Study to Evaluate the QTC Interval in Healthy Volunteers Dosed With Dexpramipexole (QTC = Electrocardiogram (ECG) Interval Measured From the Onset of the QRS Complex to the End of the T Wave Corrected for Heart Rate)

Clinical trial NCT01511029 · COMPLETED

Trial details

NCT number
NCT01511029
Sponsor
Knopp Biosciences
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2012-01-01
Primary completion
2012-05-01
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.